Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing

Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing

Abstract Background Venous thromboembolism (VTE) frequently occurs in hospitalized patients with coronavirus disease 2019 (COVID‐19). The optimal dose of anticoagulation for thromboprophylaxis in COVID‐19 is unknown. Aims To report VTE incidence and bleeding before and after implementing a hospital‐...

Full description

Bibliographic Details
Main Authors: Matthias M. Engelen, Christophe Vandenbriele, Valérie Spalart, Caroline P. Martens, Bert Vandenberk, Pieter Sinonquel, Natalie Lorent, Paul De Munter, Rik Willems, Joost Wauters, Alexander Wilmer, Dieter Dauwe, Jan Gunst, Ipek Guler, Stefan Janssens, Kimberly Martinod, Griet Pieters, Kathelijne Peerlinck, Peter Verhamme, Thomas Vanassche
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
anticoagulants
COVID‐19
hemorrhage
heparin
low‐molecular‐weight
thrombosis
Online Access:https://doi.org/10.1002/rth2.12683

Internet

https://doi.org/10.1002/rth2.12683

Similar Items